Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
Akebia Therapeutics: Q4 Earnings Snapshot
Akebia Therapeutics: Q4 Earnings Snapshot
Associated Press Finance
Thu, February 26, 2026 at 9:30 PM GMT+9 1 min read
In this article:
AKBA
-2.42%
CAMBRIDGE, Mass. (AP) — CAMBRIDGE, Mass. (AP) — Akebia Therapeutics Inc. (AKBA) on Thursday reported a loss of $12.2 million in its fourth quarter.
The Cambridge, Massachusetts-based company said it had a loss of 5 cents per share.
The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 3 cents per share.
The kidney disease treatment developer posted revenue of $57.6 million in the period, exceeding Street forecasts. Three analysts surveyed by Zacks expected $47.2 million.
For the year, the company reported that its loss narrowed to $5.3 million, or 2 cents per share. Revenue was reported as $236.2 million.
The company’s shares closed at $1.22. A year ago, they were trading at $1.82.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on AKBA at https://www.zacks.com/ap/AKBA
Terms and Privacy Policy
Privacy Dashboard
More Info